BioSpace News Archive

MicroPort Scientific Corporation announced on October 4th, 2021, through its critical care subsidiary, MicroPort Surgical B.V., has acquired 100% of the equity held by existing shareholders of Hemovent GmbH for a total cash consideration of up to €123 million.

The Jackson Laboratory, an independent, nonprofit biomedical research institution, announced the appointment of Lon Cardon, Ph.D., FMedSci, a pioneer in human genetics and drug discovery, as its next president and chief executive officer.

San Diego, Speid & Associates announces that Drug Development Boot Camp® will take place VIRTUALLY, and in person (public health conditions permitting), at The Harvard Club, 374 Commonwealth Avenue, Boston, on November 17-18, 2021.

ERYTECH Pharma (Nasdaq & Euronext: ERYP), today announced the MTD has been declared in a Phase 1 investigator sponsored clinical trial (IST), named rESPECT, of its lead product candidate eryaspase for the first-line treatment of pancreatic cancer, defining the recommended dose for future clinical trials in this indication at 100 U/kg.

OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced its continued support for the American Academy for Cerebral Palsy and Developmental Medicine, which will take place virtually October 6th – 9th.

Galapagos NV (Euronext & NASDAQ: GLPG) todayannouncedresults of twopost-hoc analyses from the SELECTION and SELECTION LTEstudies, which are part of the investigational clinical program for filgotinib, forthe treatment of patients with moderately to severely activeUC.

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, reported the grant of non-qualified stock options to purchase an aggregate of 8,620 shares of common stock of the company and 2,880 restricted stock units of the company’s common stock to one newly hired non-executive officer employee of the company.

Augmedix, Inc. (OTCQX: AUGX), a leading provider of virtual medical documentation and live clinical support, today announced preliminary unaudited financial and operational results for the three months ended September 30, 2021.

Amgen (NASDAQ:AMGN) today announced results from real-world data in Asia, Europe, Oceania, and North and South America on the temporal trends in hip fracture incidence, and in post-fracture pharmacological treatment intervention.

Billions of dollars are spent every year because of complications of wound healing. Researchers at the College of Medicine at the University of Central Florida in Orlando have discovered a new technology to accelerate wound healing.